Pharmacolog appoints Liselotte Söder as CFO. Liselotte has extensive experience of financial management in listed companies and will take up her position on 1 January 2021. Liselotte most recently came from Unibap AB (publ), where she worked as Finance Manager.
In her role as CFO, Liselotte will lead the company’s finance and accounting function and continue the work of developing the company’s financial strategy. She has been active in the accounting and tax area for more than 25 years, among other things through the operation of her own accounting firm. Liselotte has also been an employed office manager and senior consultant with assignments as CFO and interim CFO. She most recently came from an interim assignment as Finance Manager for First North-listed Unibap AB (publ). Liselotte will be part of the company’s management team and will replace outgoing CFO Jörgen Jonsson.
CEO Mats Högberg comments. “We are very happy that Liselotte has chosen to accept the role of CFO. As we are facing an exciting phase with increased growth in several markets, we need an experienced CFO. I would also like to take this opportunity to thank Jörgen for an exceptionally good collaboration and wish him luck in his new assignment.”
Liselotte Söder, incoming CFO comments. “It will be very exciting to work with Pharmacolog, a listed company with the ambition to grow. With my previous experience and ability to achieve the goals I and the company’s management set, I hope to be able to contribute to Pharmacolog’s continued development and growth.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release